Insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its Omnipod 5 insulin delivery Pods in the U.S ...

A tear in the tubing may prevent users from getting full insulin doses. So far 18 people have reported serious issues related ...

Earlier this week, Insulet announced a voluntary medical device correction and recall for specific Omnipod 5 pod lots in the ...

An insulin pump maker is recalling certain pods that can fail to fully infuse insulin in the body. The recall comes after 18 reports of “serious adverse events." ...

Insulet’s modeled fair value per share has been tweaked from US$354.40 to US$354.12, a very small adjustment that still caught investors’ attention. That subtle move lines up with a research backdrop ...

The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...

Insulet Corp. PODD shares are down during Friday’s premarket session following the company’s announcement of a voluntary ...

Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is aware of 18 cases of serious complications related to the under-delivery of ...

Insulet Corp. has identified a manufacturing issue with some of its medical devices that provide automated insulin delivery.

Insulet Corporation (NASDAQ:PODD) reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the consensus of $414.383 million. Total Omnipod revenue of $422 million marked ...

OAKVILLE, ON, April 7, 2025 /CNW/ - Insulet Corporation (PODD), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that Omnipod 5 is now ...